Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: an overview.

× No keyword cloud information.

10 in total

Review 1. Modern pharmacotherapies for type 2 diabetes mellitus.

Authors: S H Hsia
Journal: J Natl Med Assoc Date: 2001-09 Impact factor: 1.798

Review 2. Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments.

Authors: A J Scheen
Journal: Drugs Date: 1997-09 Impact factor: 9.546

3. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.

Authors: H Vestergaard; S Lund; C Bjørbaek; O Pedersen
Journal: Diabetologia Date: 1995-10 Impact factor: 10.122

4. Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.

Authors: B H Wolffenbuttel; L Nijst; J P Sels; P P Menheere; P G Müller; A C Kruseman
Journal: Eur J Clin Pharmacol Date: 1993 Impact factor: 2.953

Review 5. Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.

Authors: Momir Mikov; Maja Đanić; Nebojša Pavlović; Bojan Stanimirov; Svetlana Goločorbin-Kon; Karmen Stankov; Hani Al-Salami
Journal: Eur J Drug Metab Pharmacokinet Date: 2018-06 Impact factor: 2.441

6. Efficacy of combination therapy in non-insulin dependent diabetes mellitus.

Authors: M E Griffin; N Black; L Giblin; N M O'Meara; R G Firth
Journal: Ir J Med Sci Date: 1997 Oct-Dec Impact factor: 1.568

7. Effects of glipizide on glucose metabolism and muscle content of the insulin-regulatable glucose transporter (GLUT 4) and glycogen synthase activity during hyperglycaemia in type 2 diabetic patients.

Authors: O Schmitz; S Lund; J F Bak; L Orskov; P H Andersen; N Møller; O Rasmussen; J S Christiansen; O Pedersen
Journal: Acta Diabetol Date: 1994-04 Impact factor: 4.280

8. Myocardial glucose utilisation in type II diabetes mellitus patients treated with sulphonylurea drugs.

Authors: Ikuo Yokoyama; Yusuke Inoue; Toshiyuki Moritan; Kuni Ohtomo; Ryozo Nagai
Journal: Eur J Nucl Med Mol Imaging Date: 2006-03-10 Impact factor: 9.236

9. Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus.

Authors: M E Britton; A E Denver; V Mohamed-Ali; J S Yudkin
Journal: Clin Drug Investig Date: 1998 Impact factor: 3.580

10. Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose.

Authors: Po-Hsun Chen; Yi-Ting Tsai; Jun-Sing Wang; Shi-Dou Lin; Wen-Jane Lee; Shih-Li Su; I-Te Lee; Shih-Te Tu; Yao-Hsien Tseng; Wayne H-H Sheu; Shih-Yi Lin
Journal: Diabetol Metab Syndr Date: 2014-05-31 Impact factor: 3.320

10 in total